在多发性骨髓瘤治疗中,SLAMF7是有前途的免疫治疗标

Emily Chu1,2, Jian Wu1, Stacey S Kang3

  • 1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

PubMed
概括

在多发性骨髓瘤 (MM) 治疗中,SLAMF7 是一个有前途的标. 反SLAMF7单克隆抗体显示有效性,但耐药性需要进一步研究MM病原和SLAMF7通路.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K